Jubiglim M 2 Tablet PR
By Jubiglim M
Rx
10 Tablet PR in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg)

Manufacturer - Jubilant Life Sciences
1A, Sector 16A, Noida - 201 301, Uttar Pradesh, India

Expires on or after
April, 2026

liver
Jubiglim M 2 Tablet PR should be used carefully by individuals with liver disease. Adjusting the dose of Jubiglim M 2 Tablet PR may be necessary, so it's vital to seek advice from your healthcare provider. Typically, Jubiglim M 2 Tablet PR is initiated at a low dosage for those with mild to moderate liver issues. However, it is advised to avoid using this medication in individuals with severe liver disease. If you have liver concerns, consult your doctor before using Jubiglim M 2 Tablet PR.

kidney
Caution should be exercised with Jubiglim M 2 Tablet PR in patients with kidney disease. Dose adjustment may be necessary, and it is advised to consult your doctor. Avoid use in severe kidney disease. Regular kidney function tests are recommended during treatment.

alcohol
It is not safe to drink alcohol while taking Jubiglim M 2 Tablet PR.

driving
When taking Jubiglim M 2 Tablet PR, avoid driving if you experience low or high blood sugar symptoms that can affect your ability to drive safely.

pregnancy
Jubiglim M 2 Tablet PR may not be safe during pregnancy. Animal studies indicate potential harm to the developing baby. Consult your doctor, as they will assess the risks and benefits before prescribing this medication to you.

breastfeeding
Jubiglim M 2 Tablet PR should be avoided during breastfeeding due to potential harm to the baby.
Habit Forming | No |
Chemical Class | Biguanide |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹55
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024